Adaptive Responses of Pseudomonas aeruginosa to Treatment with Antibiotics-Reference-Cited by-同舟云学术

Adaptive Responses of Pseudomonas aeruginosa to Treatment with Antibiotics

Published:2022-01-18 Issue:1 Volume:66 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Wüllner Dominik¹^ORCID,Gesper Maren¹,Haupt Annika¹,Liang Xiaofei²^ORCID,Zhou Pei²³^ORCID,Dietze Pascal¹,Narberhaus Franz⁴^ORCID,Bandow Julia E.¹^ORCID

Affiliation:

1. Applied Microbiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany

2. Department of Chemistry, Duke University, Durham, North Carolina, USA

3. Department of Biochemistry, Duke University School of Medicine, Durham, North Carolina, USA

4. Microbial Biology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany

Abstract

Pseudomonas aeruginosa is among the highest priority pathogens for drug development because of its resistance to antibiotics, extraordinary adaptability, and persistence. Antipseudomonal research is strongly encouraged to address the acute scarcity of innovative antimicrobial lead structures.

Funder

German Federal State of North Rhine-Westphalia

German Federal State of North Rhine-Westphalia and the European Union, European Regional Development Fund, Investing In Your Future

HHS | National Institutes of Health

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00878-21

Reference75 articles.

1. Association between MucoidPseudomonasInfection and Bronchiectasis in Children with Cystic Fibrosis